Toronto Stock Exchange Symbol: LRI
LAVAL, QC, Feb. 9 /PRNewswire-FirstCall/ - LAB Research Inc. ("LAB Research" or the "Company"), a Canadian based global non-clinical contract research organization ("CRO"), today announced that Mr. Luc Mainville, Chief Executive Officer of the Company, will be presenting at the UBS 2009 Global Healthcare Services Conference on Wednesday February 11, 2009 at 9.30 am at the Waldorf Astoria Hotel in New York.
A live webcast of the presentation will be available on LAB Research website in the Investors section at www.labresearch.com
About LAB Research Inc.:
LAB Research is a Canadian global non-clinical contract research organization that provides contract research services to the pharmaceutical, biotechnology, agro-chemical, petro-chemical and industrial markets. LAB Research supports the development of its customers' products from three state-of-the-art facilities located in Canada, Denmark and Hungary.
LAB Research's shares trade on The Toronto Stock Exchange ("TSX") under the symbol "LRI", with 18.1 million shares outstanding.
This news release contains certain forward-looking statements that reflect the current views and/or expectations of LAB Research Inc. with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly.
CONTACT: visit LAB Research's website at www.labresearch.com, or contact:
Luc Mainville, Chief Executive Officer, (450) 973-2240, (ext. 1206),
email@example.com; Frederic Dumais, Jasmin-Dumais Financial
Communications, (514) 862-1251, firstname.lastname@example.org